FierceBiotech 2026-02-11 Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
FierceBiotech 2026-02-10 Kailera, Hengrui tout up to 12% weight loss in midstage study for obesity pill
FierceBiotech 2026-02-10 Merck teams up with British medtech to boost vaginal therapeutics delivery system
FierceBiotech 2026-02-10 AstraZeneca reveals oral GLP-1 scored phase 2 wins but holds back weight loss data
FierceBiotech 2026-02-10 Nektar eczema candidate 'checked all of the boxes' in long-term phase 2 data
FierceBiotech 2026-02-10 FDA rejects Regenxbio's gene therapy in Hunter syndrome, leaving CEO 'concerned'
FierceBiotech 2026-02-09 FDA slaps highest-risk recall notice on J&J Medtech Cerepak detachable coils
FierceBiotech 2026-02-09 Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'
FierceBiotech 2026-02-09 CSL signs on to $328M research collab with option for Memo’s immunoglobulin antibody tech
FierceBiotech 2026-02-09 The Data Multiplier Effect: When Expertise, Monitoring, Systems, and AI Align
FierceBiotech 2026-02-06 UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge
FierceBiotech 2026-02-06 Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study
FierceBiotech 2026-02-06 Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk